Private Trust Company’s Veracyte VCYT Stock Holding History

Private Trust Company’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-115	Closed	-$2.57K	–	2434
2023 Q3	$2.57K	Hold	115	–	–	﹤0.01%	2072
2023 Q2	$2.93K	Hold	115	–	–	﹤0.01%	2034
2023 Q1	$2.56K	Hold	115	–	–	﹤0.01%	2034
2022 Q4	$3K	Buy	115 +20	+21%	+$465	﹤0.01%	1971
2022 Q3	$2K	Hold	95	–	–	﹤0.01%	1911
2022 Q2	$2K	Buy	+95	New	+$1.92K	﹤0.01%	2000

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Private Trust Company's VCYT Position: Q4 2023 in Review

Private Trust Company sold out of Veracyte (VCYT) in Q4 2023, closing a stake of 115 shares — an estimated $2.57K sold.

Private Trust Company first reported a position in VCYT in Q2 2022 and held it in 6 quarters. The position peaked at $3K in Q4 2022. 250 funds tracked by Wall St. Rank hold VCYT as of Q4 2023.

Private Trust Company reported no remaining Veracyte position as of Q4 2023 after selling out during the quarter.
Private Trust Company sold 115 Veracyte shares in Q4 2023, an estimated $2.57K.
Private Trust Company first reported a position in Veracyte in Q2 2022 and held it in 6 quarters.
Private Trust Company's Veracyte position peaked at $3K in Q4 2022.
250 funds tracked by Wall St. Rank held Veracyte as of Q4 2023.

Based on Private Trust Company's 13F filing for Q4 2023, filed 24 Jan 2024.